Display Settings:

Format

Send to:

Choose Destination
Med J Aust. 2009 Apr 6;190(7):388-9.

Pertussis prevention and treatment: a call for wider access to azithromycin.

Author information

  • 1Sydney Children's Hospital, Sydney, NSW, Australia.

Abstract

Azithromycin is recommended as the first-line antibiotic for the prophylaxis and treatment of pertussis, a common vaccine-preventable communicable disease. Azithromycin is better tolerated than other macrolide antibiotics. Access to azithromycin is limited, as the product information and the Pharmaceutical Benefits Scheme do not include azithromycin for pertussis. Issues regarding access to azithromycin are highlighted in a case report of pertussis exposure in a tertiary paediatric hospital.

PMID:
19351315
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Australasian Medical Publishing Company
    Loading ...
    Write to the Help Desk